New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial.

CONCLUSION: HL tablet is effective in reducing HFC without any negative lipid profiles, BMI changes and adverse effects. PMID: 28932090 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28932090?dopt=Abstract

Source: World Journal of Gastroenterology : WJG - August 28, 2017 Category: Gastroenterology Authors: Jeong JY, Sohn JH, Baek YH, Cho YK, Kim Y, Kim H Tags: World J Gastroenterol Source Type: research